Summary
- Splice variants
- Transcript comparison
- Gene alleles
Sequence
- Secondary Structure
Comparative Genomics
- Genomic alignments
- Gene tree
- Gene gain/loss tree
- Orthologues
- Paralogues
Ontologies
- GO: Anatomical entity
Phenotypes
Genetic Variation
Gene expression
Pathway
Molecular interactions
External references
Supporting evidence
ID History
- Gene history

Configure this page

Share this page

Bookmark this page

.

Gene: tsnaxip1 ENSDARG00000030512

.

Description

translin-associated factor X interacting protein 1 [Source:NCBI gene (formerly Entrezgene);Acc:565917]

Location

Chromosome 18: 21,931,741-21,950,751 reverse strand.

GRCz11:CM002902.2

About this gene

This gene has 3 transcripts (splice variants) and 40 orthologues.

Transcripts

Show transcript tableHide transcript table

Transcript ID	Name	bp	Protein	Translation ID	Biotype	UniProt Match	Flags
ENSDART00000043452.8	tsnaxip1-201	2605	673aa	ENSDARP00000043451.7	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A5WVR3	A single transcript chosen for a gene which is the most conserved, most highly expressed, has the longest coding sequence and is represented in other key resources, such as NCBI and UniProt. This is defined in detail on http://www.ensembl.org/info/genome/genebuild/canonical.htmlEnsembl Canonical, APPRIS P1: Transcript(s) expected to code for the main functional isoform based solely on the core modules in the APPRIS. APPRIS is a system to annotate alternatively spliced transcripts based on a range of computational methods to identify the most functionally important transcript(s) of a gene. APPRIS P1,
ENSDART00000135546.2	tsnaxip1-202	842	No protein	-	An alternatively spliced transcript believed to contain intronic sequence relative to other, coding, transcripts of the same gene.Retained intron	-	-
ENSDART00000148104.2	tsnaxip1-203	564	No protein	-	An alternatively spliced transcript believed to contain intronic sequence relative to other, coding, transcripts of the same gene.Retained intron	-	-

.

Summary

.

.